Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2006 Jan 23;3(1):99–107. doi: 10.1093/ecam/nek013

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author (2006). Published by Oxford University Press. All rights reserved

The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

PMC Copyright notice

(a) Histogram showing changes in hemoglobin content of subjects fed either placebo or drug (Ars alb-30) of 1 month treatment against negative control; statistical significance levels calculated by considering differences between data of subjects of Group I and Group II, and within Group II before and after administration of either placebo (BP) or verum (BD-30); ^aP < 0.05; ^bP < 0.01; ^cP < 0.001. (b) Histogram showing changes in hemoglobin content of subjects fed drug (Ars alb-30) for 2 months against negative control; statistical significance levels were calculated by considering differences between Group I and Group III before drug administration and within Group III before and after administration of the drug (Ars alb-30). (c) Histogram showing changes in hemoglobin content of subjects fed drug (Ars alb-200) for 2 months; statistical significance levels were calculated between Group I and Group IV before administration of the drug and within Group IV before and after administration of the drug (Ars alb-200).